All Stories

  1. Targeting autophagy with natural products to prevent SARS-CoV-2 infection
  2. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy
  3. Inhibition of Autophagy In Vivo Extends Methamphetamine Toxicity to Mesencephalic Cell Bodies
  4. Caesalpinia mimosoides Leaf Extract Promotes Neurite Outgrowth and Inhibits BACE1 Activity in Mutant APP-Overexpressing Neuronal Neuro2a Cells
  5. GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer
  6. Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse
  7. BECN1 and BRCA1 Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis
  8. Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets
  9. Ovarian mitochondrial dynamics and cell fate regulation in an androgen-induced rat model of polycystic ovarian syndrome
  10. Autophagy drives osteogenic differentiation of human gingival mesenchymal stem cells
  11. Amino acid response by Halofuginone in Cancer cells triggers autophagy through proteasome degradation of mTOR
  12. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts
  13. Autophagy-dependent toxicity of amino-functionalized nanoparticles in ovarian cancer cells
  14. Multifunctional Gd-based mesoporous silica nanotheranostic for anticancer drug delivery
  15. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway
  16. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells
  17. Lysophosphatidic Acid Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response
  18. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
  19. The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells
  20. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation
  21. Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer’s Disease
  22. Dopamine exacerbates mutant Huntingtin toxicity via oxidative-mediated inhibition of autophagy in SH-SY5Y neuroblastoma cells: Beneficial effects of anti-oxidant therapeutics
  23. PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells
  24. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy
  25. B34 Dopamine imbalance in huntington’s disease: when the inhibition of autophagy can lead to cell catastrophe
  26. Transcriptomic analysis of the autophagy machinery in crustaceans
  27. Coordinated Metabolic Changes and Modulation of Autophagy during Myogenesis
  28. The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders
  29. The fine tuning of metabolism, autophagy and differentiation during in vitro myogenesis
  30. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  31. Report from the Second International Conference of Traditional and Complementary Medicine on Health 2015
  32. Publishing scientifically sound papers in Traditional and Complementary Medicine
  33. Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells
  34. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome
  35. autophagy and neuroprotection
  36. The Potential for Plant Derivatives against Acrylamide Neurotoxicity
  37. Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis
  38. NaGdF4 Nanoparticles Coated with Functionalised Ethylenediaminetetraacetic Acid as Versatile Probes for Dual Optical and Magnetic Resonance Imaging
  39. PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells
  40. Turmeric Toxicity in A431 Epidermoid Cancer Cells Associates with Autophagy Degradation of Anti‐apoptotic and Anti‐autophagic p53 Mutant
  41. Epigenetic Control of Autophagy by MicroRNAs in Ovarian Cancer
  42. Single Amino Acid Arginine Deprivation Triggers Prosurvival Autophagic Response in Ovarian Carcinoma SKOV3
  43. Expression and Clinical Significance of the Autophagy Proteins BECLIN 1 and LC3 in Ovarian Cancer
  44. Autophagy and thyroid carcinogenesis: genetic and epigenetic links
  45. Protection from UVB Toxicity in Human Keratinocytes by Thailand Native Herbs Extracts
  46. Knockdown of cathepsin D in zebrafish fertilized eggs determines congenital myopathy
  47. Similarities and differences in the biogenesis, processing and lysosomal targeting between zebrafish and human pro-Cathepsin D: Functional implications
  48. Cathepsins: Getting in Shape for Lysosomal Proteolysis
  49. Involvement of autophagy in ovarian cancer: a working hypothesis
  50. Defective Autophagy in Parkinson’s Disease: Role of Oxidative Stress
  51. Dopamine induces apoptosis in APPswe-expressing Neuro2A cells following Pepstatin-sensitive proteolysis of APP in acid compartments
  52. Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups
  53. DNA damage response by single-strand breaks in terminally differentiated muscle cells and the control of muscle integrity
  54. Labeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles
  55. Guidelines for the use and interpretation of assays for monitoring autophagy
  56. Thyroid incidentaloma identified by 18 F‐fluorodeoxyglucose positron emission tomography with CT (FDG‐PET/CT): clinical and pathological relevance
  57. Induced autophagy reduces virus output in dengue infected monocytic cells
  58. Chelation of Lysosomal Iron Protects Dopaminergic SH-SY5Y Neuroblastoma Cells from Hydrogen Peroxide Toxicity by Precluding Autophagy and Akt Dephosphorylation
  59. Knock-Down of Cathepsin D Affects the Retinal Pigment Epithelium, Impairs Swim-Bladder Ontogenesis and Causes Premature Death in Zebrafish
  60. Patented Biomarkers for the Early Detection of Ovarian Cancer
  61. Resveratrol Reduces the Invasive Growth and Promotes the Acquisition of a Long-Lasting Differentiated Phenotype in Human Glioblastoma Cells
  62. Patented Biomarkers for the Early Detection of Ovarian Cancer
  63. The dilemma: Does tissue expression of cathepsin D reflect tumor malignancy? The question: Does the assay truly mirror cathepsin D mis-function in the tumor?
  64. Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas
  65. Inhibition of PI3k Class III–Dependent Autophagy Prevents Apoptosis and Necrosis by Oxidative Stress in Dopaminergic Neuroblastoma Cells
  66. Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells
  67. Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis
  68. High Expression of Cathepsin D in Non-Hodgkin’s Lymphomas Negatively Impacts on Clinical Outcome
  69. Autophagy, lithium, and amyotrophic lateral sclerosis
  70. Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D‐Bax activation loop
  71. Photoactive Hybrid Nanomaterials: Indocyanine Immobilized in Mesoporous MCM-41 for “In-Cell” Bioimaging
  72. Correction for Fornai et al. , Lithium delays progression of amyotrophic lateral sclerosis
  73. Role of Autophagy during Methamphetamine Neurotoxicity
  74. Akt Induces Apoptosis in Neuroblastoma Cells Expressing a C98X Vasopressin Mutant Following Autophagy Suppression
  75. Prolactin Promotes the Secretion of Active Cathepsin D at the Basal Side of Rat Mammary Acini
  76. Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine
  77. Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium
  78. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression
  79. Lithium delays progression of amyotrophic lateral sclerosis
  80. A fast and simple method for simultaneous mixed site‐specific mutagenesis of a wide coding sequence
  81. Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes
  82. The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle
  83. Cathepsin D–Bax death pathway in oxidative stressed neuroblastoma cells
  84. Folding, activity and targeting of mutated human cathepsin D that cannot be processed into the double-chain form
  85. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D
  86. PI3K-dependent lysosome exocytosis in nitric oxide-preconditioned hepatocytes
  87. Prognostic significance of microvessel density and vascular endothelial growth factor expression in sinonasal carcinomas☆
  88. cFLIP expression correlates with tumour progression and patient outcome in non‐Hodgkin lymphomas of low grade of malignancy
  89. High yield synthesis and characterization of phosphorylated recombinant human procathepsin D expressed in mammalian cells
  90. Autophagy-dependent cell survival and cell death in an autosomal dominant familial neurohypophyseal diabetes insipidus in vitro model
  91. Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene
  92. Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions
  93. Preconditioning-induced cytoprotection in hepatocytes requires Ca2+-dependent exocytosis of lysosomes
  94. Destination ‘Lysosome’: a target organelle for tumour cell killing?
  95. Endosomal-Lysosomal Proteolysis Mediates Death Signalling by TNFα, Not by Etoposide, in L929 Fibrosarcoma Cells: Evidence for an Active Role of Cathepsin D
  96. Increase in Ceramide Level Alters the Lysosomal Targeting of Cathepsin D prior to Onset of Apoptosis in HT-29 Colon Cancer Cells
  97. Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas
  98. Expression of protein kinase C ?1 confers resistance to TNF?- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells
  99. Transformation by oncogenic ras‐p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D
  100. Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D
  101. Regulation of rat hepatocyte protein kinase C ? isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: A signaling pathway to modulate vesicular transport of glycoproteins
  102. Lysosomal segregation of a mannose-rich glycoprotein imparted by the prosequence of myeloperoxidase
  103. Human and hamster procathepsin D, although equally tagged with mannose-6-phosphate, are differentially targeted to lysosomes in transfected BHK cells
  104. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line
  105. Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal
  106. Differential targeting and processing of procathepsin D in normal and transformed murine 3T3 fibroblasts
  107. Exposed Thiols Confer Localization in the Endoplasmic Reticulum by Retention Rather than Retrieval
  108. Synthesis, maturation and extracellular release of procathepsin D as influenced by cell proliferation or transformation
  109. Differentiation-dependent autophagy controls the fate of newly synthesized N-linked glycoproteins in the colon adenocarcinoma HT-29 cell line
  110. Localization and Processing of Glycosylphosphatidylinositol-Anchored Cathepsin D
  111. A Heterotrimeric G-protein Controls Autophagic Sequestration in the Human Colon Cancer Cell Line HT-29
  112. Altered intracellular processing and enhanced secretion of procathepsin D in a highly deviated rat hepatoma
  113. Effects of Calcitriol on the Biogenesis of a Lysosomal Protease in Monocytes from Patients with Renal Failure
  114. Role of monocytes in cryoglobulinemia-associated nephritis
  115. Serum and Intracellular Detection of Cytokines in Patients Undergoing Chronic Hemodialysis
  116. Differential segregation of human and hamster cathepsin D in transfected baby-hàmster kidney cells
  117. Altered transport and processing of cathepsin D in human tumour cells with metastatic phenotype
  118. Suppression of the ‘uncovering’ of mannose‐6‐phosphate residues in lysosomal enzymes in the presence of NH4Cl
  119. Brefeldin A Prevents Uncovering but not Phosphorylation of the Recognition Marker in Cathepsin D
  120. Regulation of Protein Degradation in Neoplastic Cells
  121. Characterization of cathepsin D in ascites hepatoma cells and in the liver of tumour-bearing animals*1
  122. Regulation of lysosomal cysteine-proteinase activities in 3T3 and SV-3T3 cells*
  123. The transport of soluble lysosomal hydrolases from the Golgi complex to lysosomes